AI assistant
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2025
Nov 25, 2025
31542_dirs_2025-11-24_62f4d71f-9326-4530-bf3c-02be3b2ba179.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2025-11-20
Reporting Person: Kalb Michael Wayne (Executive Vice President & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-21 | Common Stock, par value $0.001 per share | M | 6894 | — | Acquired | 11091 | Direct |
| 2025-11-21 | Common Stock, par value $0.001 per share | F | 2485 | — | Disposed | 8606 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-11-20 | Options to purchase common stock | $22.77 | A | 131536 | Acquired | 2032-11-20 | Common Stock (131536) | Direct |
| 2025-11-20 | Restricted Stock Units | $ | A | 39701 | Acquired | Common Stock (39701) | Direct | |
| 2025-11-21 | Restricted Stock Units | $ | M | 6894 | Disposed | Common Stock (6894) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F2: Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted common stock.
F3: Derivative securities vest in equal tranches, 1/3rd on November 20, 2026, 1/3rd on November 20, 2027 and 1/3rd on November 20, 2028.
F4: Shares of common stock will be delivered to the Reporting Person upon vesting.
F5: Derivative securities vest in equal tranches, 1/3rd on November 21, 2025, 1/3rd on November 21, 2026, and 1/3rd on November 21, 2027.
F6: Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on November 21, 2025.